As those of you on the DXB forum know, DXB has been slow cooking for a while now. For me the buy signals were:
1. Very strong OBV.
2. Commencement of the current short term uptrend which in turn followed a retrace to the vicinity of the neckline after the initial breakout from the neckline.
The story is good, and will get better once Dimerix are in a position to introduce a sustained release form of propagermanium. Cutting out the middle of the day dosage should do wonders for patient compliance down the track.
Chartwatch - DXB
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
49.5¢ |
Change
-0.010(1.98%) |
Mkt cap ! $272.1M | |||
| Open | High | Low | Value | Volume |
| 53.5¢ | 56.0¢ | 49.5¢ | $5.631M | 10.71M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 440427 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.0¢ | 1000 | 1 |
View Market Depth
| Last trade - 16.10pm 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
49.5¢ |
Change
-0.010 ( 2.10 %) |
||||
| Open | High | Low | Volume | ||
| 53.5¢ | 56.0¢ | 49.5¢ | 6482131 | ||
| Last updated 15.59pm 04/06/2024 ? | |||||
| DXB (ASX) Chart |